|
|
Volumn 351, Issue 6268, 2016, Pages 12-13
|
|
As Ebola epidemic draws to a close, a thin scientific harvest: Thirteen clinical trials in West Africa have yielded only one unequivocally positive result
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EBOLA VACCINE;
ANTIVIRUS AGENT;
BRINCIDOFOVIR;
CYTOSINE;
PHOSPHONIC ACID DERIVATIVE;
DISEASE CONTROL;
EPIDEMIC;
TESTING METHOD;
VIRAL DISEASE;
AFRICA;
ARTICLE;
CLINICAL TRIAL (TOPIC);
DONOR;
EBOLA HEMORRHAGIC FEVER;
EPIDEMIC;
HUMAN;
PLASMA;
PRIORITY JOURNAL;
SURVIVOR;
ANALOGS AND DERIVATIVES;
DRUG EFFECTS;
EBOLAVIRUS;
HEALTH;
HEMORRHAGIC FEVER, EBOLA;
WORLD HEALTH ORGANIZATION;
WEST AFRICA;
AFRICA, WESTERN;
ANTIVIRAL AGENTS;
CLINICAL TRIALS AS TOPIC;
CYTOSINE;
EBOLA VACCINES;
EBOLAVIRUS;
EPIDEMICS;
GLOBAL HEALTH;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
ORGANOPHOSPHONATES;
WORLD HEALTH ORGANIZATION;
|
|
EID: 84952927765
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.351.6268.12 Document Type: Article |
|
Times cited : (21)
|
|
References (0)
|